KR780000433B1 - Process for manufactirung coronary agent in special form - Google Patents

Process for manufactirung coronary agent in special form

Info

Publication number
KR780000433B1
KR780000433B1 KR7201276A KR720001276A KR780000433B1 KR 780000433 B1 KR780000433 B1 KR 780000433B1 KR 7201276 A KR7201276 A KR 7201276A KR 720001276 A KR720001276 A KR 720001276A KR 780000433 B1 KR780000433 B1 KR 780000433B1
Authority
KR
South Korea
Prior art keywords
manufactirung
special form
coronary
agent
coronary agent
Prior art date
Application number
KR7201276A
Other languages
Korean (ko)
Inventor
Vater Wulf
Bossert Friedrich
Adams Karl-Heinz
Bauer Kurt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25761638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR780000433(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19722209526 external-priority patent/DE2209526C3/en
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of KR780000433B1 publication Critical patent/KR780000433B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00—Special receptacle or package
    • Y10S206/828—Medicinal content

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Hydrogenated Pyridines (AREA)
KR7201276A 1971-08-24 1972-08-24 Process for manufactirung coronary agent in special form KR780000433B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2142316 1971-08-24
DE19722209526 DE2209526C3 (en) 1972-02-29 1972-02-29 Coronary therapeutic agent in the form of gelatine capsules

Publications (1)

Publication Number Publication Date
KR780000433B1 true KR780000433B1 (en) 1978-10-14

Family

ID=25761638

Family Applications (1)

Application Number Title Priority Date Filing Date
KR7201276A KR780000433B1 (en) 1971-08-24 1972-08-24 Process for manufactirung coronary agent in special form

Country Status (25)

Country Link
US (1) US3784684A (en)
JP (2) JPS5434048B2 (en)
KR (1) KR780000433B1 (en)
BE (1) BE787951A (en)
BG (1) BG27728A3 (en)
CA (1) CA981582A (en)
CY (1) CY918A (en)
DD (1) DD99729A5 (en)
DK (1) DK130628B (en)
EG (1) EG10633A (en)
ES (1) ES406047A1 (en)
FI (1) FI53922C (en)
FR (1) FR2150848B1 (en)
GB (1) GB1362627A (en)
HK (1) HK44877A (en)
IE (1) IE36891B1 (en)
IL (1) IL40165A (en)
KE (1) KE2756A (en)
LU (1) LU65929A1 (en)
MY (1) MY7800003A (en)
NL (1) NL176836C (en)
NO (1) NO138167C (en)
RO (1) RO88521B (en)
SG (1) SG34877G (en)
SU (1) SU432703A3 (en)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (en) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
ZA725808B (en) * 1971-08-24 1973-05-30 Bayer Ag A coronary agent in special form and processes for its manufacture
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions
BE825842A (en) * 1974-02-22 1975-08-21 PHARMACEUTICAL COMPOSITIONS INCLUDING DIGOXIN
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4056610A (en) * 1975-04-09 1977-11-01 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
JPS52151724A (en) * 1976-06-07 1977-12-16 Takeda Chem Ind Ltd Hard shell gelatin capsule
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS5484023A (en) * 1977-12-19 1979-07-04 Teijin Ltd Soft capsule containing active vitamin d3, and its preparation
JPS5522631A (en) * 1978-08-07 1980-02-18 Ota Seiyaku Kk Readily absorbable nifedipine preparation
JPS5522645A (en) * 1978-08-07 1980-02-18 Fujisawa Pharmaceut Co Ltd Soft capsule for encapsulation of light-unstable compound
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
JPS5939827A (en) * 1982-08-27 1984-03-05 Nitto Electric Ind Co Ltd External member for medical use
DE3307353C2 (en) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Soft gelatin capsule containing polyethylene glycol and process for their production
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307422A1 (en) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen LIQUID PREPARATIONS OF DIHYDROPYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
ATE33348T1 (en) * 1983-11-30 1988-04-15 Siegfried Ag CORONAR THERAPY IN THE FORM OF SOFT GELATIN CAPSULES.
DE3419129A1 (en) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen NIFEDIPINE PREPARATIONS AND METHOD FOR THE PRODUCTION THEREOF
DE3419130A1 (en) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen NIFEDIPINE COMBINATION PREPARATIONS AND METHOD FOR THEIR PRODUCTION
US5266581A (en) * 1984-07-04 1993-11-30 Bayer Aktiengesellschaft Solid composition containing dihydropyridine, PVP and PVPP
EP0175671A1 (en) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmaceutical preparation and method for the administration of this pharmaceutical preparation
DE3438830A1 (en) * 1984-10-23 1986-04-30 Rentschler Arzneimittel PHARMACEUTICAL FORM CONTAINING NIFEDIPIN AND METHOD FOR THE PRODUCTION THEREOF
DE3532129A1 (en) * 1985-09-10 1987-03-12 Bayer Ag GELATINE CONTAINING SS CAROTINE
GB8522453D0 (en) * 1985-09-11 1985-10-16 Lilly Industries Ltd Chewable capsules
DE3544692A1 (en) * 1985-12-18 1987-06-19 Bayer Ag DIHYDROPYRIDINE SPRAY, METHOD FOR THE PRODUCTION THEREOF AND ITS PHARMACEUTICAL USE
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
DE3636123A1 (en) * 1986-10-23 1988-05-05 Rentschler Arzneimittel ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE
DE3639418A1 (en) * 1986-11-18 1988-06-09 Forschungsgesellschaft Rauchen NICOTINE-BASED AGENT
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
EP0272336B1 (en) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Nifidipine concentrate stabilized against the influence of light, and method for its preparation
DE3714402A1 (en) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh DRUG FORMULATION
DE3738236A1 (en) * 1987-11-11 1989-05-24 Euro Celtique Sa BIT CAPSULE
US4954346A (en) * 1988-06-08 1990-09-04 Ciba-Geigy Corporation Orally administrable nifedipine solution in a solid light resistant dosage form
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
CA2056032A1 (en) * 1990-11-29 1992-05-30 Minoru Aoki Hard capsule preparation
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US6093420A (en) 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
JP4730985B2 (en) * 1997-09-10 2011-07-20 武田薬品工業株式会社 Stabilized pharmaceutical formulation
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
WO1999016417A1 (en) 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
WO2001015702A1 (en) 1999-08-31 2001-03-08 Chugai Seiyaku Kabushiki Kaisha Soft capsules
NZ511900A (en) * 1999-09-30 2003-06-30 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
JP4995407B2 (en) 2002-04-25 2012-08-08 バナー ファーマキャップス， インコーポレーテッド Chewable soft capsule
WO2003094897A1 (en) * 2002-05-09 2003-11-20 Chugai Seiyaku Kabushiki Kaisha Photostabilized soft capsule
DK1944029T3 (en) * 2005-10-31 2012-01-23 Kowa Co Pharmaceutical preparation with excellent photo stability
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
AU2008251370A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
US8497303B2 (en) * 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives
CN106344533A (en) * 2009-01-29 2017-01-25 大日本住友制药株式会社 Orally disintegrating tablet having inner core
CN102160872A (en) 2010-02-23 2011-08-24 天津天士力制药股份有限公司 Compound salvia dropping pill capsules
TWI571257B (en) * 2011-02-23 2017-02-21 Tasly Pharmaceutical Group Co Capsule preparation
ES2895161T3 (en) 2018-05-14 2022-02-17 Capsugel Belgium Nv Capsules with opacifier
AU2019285170A1 (en) 2018-06-14 2021-01-28 Astrazeneca Uk Limited Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3155587A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 7-chlorotetracycline
DE1670827C3 (en) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4- (2'-nitrophenyl) -2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine
SU432703A3 (en) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер

Also Published As

Publication number Publication date
BG27728A3 (en) 1979-12-12
ES406047A1 (en) 1981-08-16
SU432703A3 (en) 1974-06-15
MY7800003A (en) 1978-12-31
US3784684A (en) 1974-01-08
BE787951A (en) 1973-02-26
DK130628C (en) 1975-08-25
IL40165A0 (en) 1972-10-29
JPS5434048B2 (en) 1979-10-24
DK130628B (en) 1975-03-17
JPS4828621A (en) 1973-04-16
FR2150848B1 (en) 1976-04-16
CA981582A (en) 1976-01-13
IE36891B1 (en) 1977-03-16
IL40165A (en) 1975-03-13
RO88521A (en) 1987-04-30
DD99729A5 (en) 1973-08-20
CY918A (en) 1977-12-23
JPS53121921A (en) 1978-10-24
KE2756A (en) 1977-10-14
NL7211565A (en) 1973-02-27
NL176836C (en) 1985-06-17
FR2150848A1 (en) 1973-04-13
FI53922C (en) 1979-09-07
IE36891L (en) 1973-02-24
GB1362627A (en) 1974-08-07
RO88521B (en) 1987-05-01
HK44877A (en) 1977-09-09
LU65929A1 (en) 1973-01-15
NL176836B (en) 1985-01-16
NO138167C (en) 1978-07-26
FI53922B (en) 1978-05-31
SG34877G (en) 1987-04-03
EG10633A (en) 1976-08-31
NO138167B (en) 1978-04-10

Similar Documents

Publication Publication Date Title
KR780000433B1 (en) Process for manufactirung coronary agent in special form
HK24577A (en) Finishing process
ZA728621B (en) Coal-conversion process
IL38677A0 (en) Photopolymerizable composition and process for making the same
ZM1472A1 (en) Copper-producing process
ZA721557B (en) Hydrocracking process
YU45072A (en) Process for obtaining 3-methylcephalosporans
ZM13372A1 (en) Cementation process
YU142879A (en) Process for obtaining thiazoline-azetidinone
ZA725808B (en) A coronary agent in special form and processes for its manufacture
YU33128B (en) Dovodna in veckrozna zavorna naprava za priklopna vozila
YU267272A (en) Process for obtaining benzyl-pyridyl-amino-ethanol
YU37305B (en) Process for obtaining monohaloacetylhalides
YU71372A (en) Priprava za sklapljanje tirnih vozil z avtomatskimi srednjimi odbijnimi sklopkami in vozil z vijacnimi sklopkami
ZA713813B (en) Rendering process
YU278872A (en) Vlecna in potisna priprava za srediscne odbojne sklopke tirnih vozil
YU35251B (en) Process for obtaining 4-hydroxy-benzodioxole
ZA721523B (en) 17a-ethynylestriols and process for preparing same
ZA721018B (en) Benzenesulfonamidopyridines and process for their manufacture
YU33252B (en) Vlecna in udarna priprava za sklopke srednjega odbicaja tirnih vozila
YU297072A (en) Process for obtaining 7-amino-decetoxy-cephalosporinates-hydrohalides
YU34800B (en) Process for preparing 9 delta-fluoro-16-methylene-prednisolone-21-acetate
GB1406029A (en) Engraving process
ZA718417B (en) Machines and processes for making concrete articles
MY7500022A (en) New colduration process